# DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
> **ANDA207228** · Abbreviated New Drug Application (Generic) · Sponsor: AYANA PHARMA LTD · Approved 2021-10-12
## Drug
- **FDA Application Number:** ANDA207228
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
- **Generic name:** Doxorubicin Hydrochloride
- **Active ingredients:** DOXORUBICIN HYDROCHLORIDE
- **Dosage form:** INJECTABLE, LIPOSOMAL
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AYANA PHARMA LTD
- **First approval:** 2021-10-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207228)
---
*MORVS · CC0 1.0*